Most Recent
A case simultaneously challenging IP Australia's decisions to accept, grant and certify an innovation patent owned by one of Australia's biggest building product companies has been withdrawn, a court has heard.
AFT Pharmaceuticals has accused rival Reckitt Benckiser of using the court as a "clearance house" to beat its competitors, the latest development in a long-running dispute over AFT's Maxigesic ads.
Pharmaceutical giant Mylan has been ordered to hand over documents relating to its proposed launch of a generic version of its cholesterol drug Lipidil to rival Sun Pharma in advance of a hearing on Mylan's request for an order blocking Sun from launching its own generic version of the drug.
Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.
A month after Network 10 vowed to fiercely defend against a trade mark infringement case by Fairfax Media over its new '10 Boss' logo, the TV broadcaster has agreed to drop the name.
The Commissioner of Patents will seek to toss a case simultaneously challenging its decisions to accept, grant and certify an innovation patent owned by one of Australia's biggest building product firms.
A unit of Nestle unit has defeated an opposition to a patent for an internet-connected coffee machine that would allow users to read news and weather while making their morning coffee.
Network 10 told a court Thursday it would "fiercely defend" a trade mark case brought by Fairfax Media over 10's recent rebrand and its newly approved trade mark, 10 Boss.
Drug maker Neurim Pharmaceuticals is battling to amend its Australian patent for the blockbuster sleeping pill Circadin over opposition from two generic pharmaceutical companies, which have accused Neurim of attempting to gain an unfair advantage by delaying the amendment bid until now.
Fintech company Encompass has asked the Full Federal Court to take a more "nuanced" approach to software patentability than the one currently held by IP Australia, on the first day of a high-stakes appeal over the patentability of computer-related inventions.